Pharmaceutical Supply – Clindamycin Hydrochloride

The contract entails the manufacture and supply of 2,000 bottles of Clindamycin Hydrochloride, USP 150 mg/mL, a pharmaceutical product required to meet exact military specifications identified by NSN 6505001594892 and NDC 00009-0225-02. The scope focuses solely on production and delivery of this specific formulation in the designated quantity, ensuring full compliance with federal standards for quality, labeling, and packaging as mandated for defense medical use. The contract is classified as a subcontract under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency on behalf of the Department of Defense. The agreement was posted on June 26, 2026, and is associated with the military procurement system through the DIBBS platform under contract SPE2DX25D8022 and delivery order SPE2D926F6864. While no specific place of performance or point of contact is listed, the product must be delivered to meet defense medical supply chain requirements, likely for use in military healthcare facilities or operational deployments. The terms indicate strict adherence to regulatory and logistical protocols, with no set-aside provisions indicated, meaning the contract is open to qualified subcontractors irrespective of business size or status.